Essential role of ERK activation in neurite outgrowth induced by α-lipoic acid

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 5, 2011, Pages 827-838

  Wang, Xiaohui ^a   Wang, Zhuyao ^a,b   Yao, Yuzhen ^a   Li, Jingjin ^a   Zhang, Xiaojin ^a   Li, Chuanfu ^c   Cheng, Yunlin ^a   Ding, Guoxian ^a   Liu, Li ^a   Ding, Zhengnian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING NORMAL UNIVERSITY   (China)

^c East Tennessee State University   (United States)

Author keywords

Alpha lipoic acid; MEK ERK signaling pathway; Neurite outgrowth; Reactive oxygen species

Indexed keywords

BETA TUBULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; INHIBITION KINETICS; MOUSE; NERVE CELL; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIPPOCAMPUS; MICE; NEURITES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; THIOCTIC ACID;

EID: 79955656952     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.01.027     Document Type: Article

References (36)

1. Min J.Y., Park M.H., Park M.K., Park K.W., Lee N.W., Kim T., Kim H.J., Lee D.H. Staurosporin induces neurite outgrowth through ROS generation in HN33 hippocampal cell lines. J. Neural Transm. 2006, 113:1821-1826.
2. Papadopoulos C.M., Tsai S.Y., Guillen V., Ortega J., Kartje G.L., Wolf W.A. Motor recovery and axonal plasticity with short-term amphetamine after stroke. Stroke 2009, 40:294-302.
3. Schiwy N., Brazda N., Müller H.W. Enhanced regenerative axon growth of multiple fibre populations in traumatic spinal cord injury following scar-suppressing treatment. Eur. J. Neurosci. 2009, 30:1544-1553.
4. Lee W.Y., Orestes P., Latham J., Naik A.K., Nelson M.T., Vitko I., Perez-Reyes E., Jevtovic-Todorovic V., Todorovic S.M. Molecular mechanisms of lipoic acid modulation of T-type calcium channels in pain pathway. J. Neurosci. 2009, 29:9500-9509.
5. Abdul H.M., Butterfield D.A. Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Free Radic. Biol. Med. 2007, 42:371-384.
6. Karunakaran S., Diwakar L., Saeed U., Agarwal V., Ramakrishnan S., Iyengar S., Ravindranath V. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid. FASEB J. 2007, 21:2226-2236.
7. Rutkove S.B. A 52-year-old woman with disabling peripheral neuropathy: review of diabetic polyneuropathy. JAMA 2009, 302:1451-1458.
8. Melli G., Taiana M., Camozzi F., Triolo D., Podini P., Quattrini A., Taroni F. G Lauria, Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp. Neurol. 2008, 214:276-284.
9. Shenk J.C., Liu J., Fischbach K., Xu K., Puchowicz M., Obrenovich M.E., Gasimov E., Alvarez L.M., Ames B.N., Lamanna J.C., Aliev G. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. J. Neurol. Sci. 2009, 283:199-206.
10. Pouyatos B., Gearhart C., Nelson-Miller A., Fulton S., Fechter L.D. Lipoic acid and 6-formylpterin reduce potentiation of noise-induced hearing loss by carbon monoxide: preliminary investigation. J. Rehabil. Res. Dev. 2008, 45:1053-1064.
11. Wang X., Zhang X., Cheng Y., Li C., Zhang W., Liu L., Ding Z. Alpha-Lipoic acid prevents bupivacaine-induced neuron injury in vitro through a PI3K/Akt-dependent mechanism. Neurotoxicology 2010, 31:101-112.
12. Chen J., Zacharek A., Cui X., Shehadah A., Jiang H., Roberts C., Lu M., Chopp M. Treatment of stroke with a synthetic liver X receptor agonist, TO901317, promotes synaptic plasticity and axonal regeneration in mice. J. Cereb. Blood Flow Metab. 2010, 30:102-109.
13. Chen X., Fu W., Tung C.E., Ward N.L. Angiopoietin-1 induces neurite outgrowth of PC12 cells in a Tie2-independent, beta1-integrin-dependent manner. Neurosci. Res. 2009, 64:348-354.
14. Riese U., Ziegler E., Hamburger M. Militarinone A induces differentiation in PC12 cells via MAP and Akt kinase signal transduction pathways. FEBS Lett. 2004, 577:455-459.
15. Meng X.L., Rennert O.M., Chan W.Y. Human chorionic gonadotropin induces neuronal differentiation of PC12 cells through activation of stably expressed lutropin/choriogonadotropin receptor. Endocrinology 2007, 148:5865-5873.
16. Obara Y., Yamauchi A., Takehara S., Nemoto W., Takahashi M., Stork P.J., Nakahata N. ERK5 activity is required for nerve growth factor-induced neurite outgrowth and stabilization of tyrosine hydroxylase in PC12 cells. J. Biol. Chem. 2009, 284. 23564-13573.
17. Washio A., Kitamura C., Jimi E., Terashita M., Nishihara T. Mechanisms involved in suppression of NGF-induced neuronal differentiation of PC12 cells by hyaluronic acid. Exp. Cell Res. 2009, 315:3036-3043.
18. Wu H., Ichikawa S., Tani C., Zhu B., Tada M., Shimoishi Y., Murata Y., Nakamura Y. Docosahexaenoic acid induces ERK1/2 activation and neuritogenesis via intracellular reactive oxygen species production in human neuroblastoma SH-SY5Y cells. Biochim. Biophys. Acta 2009, 1791:8-16.
19. Kotake-Nara E., Saida K. Characterization of CoCl2-induced reactive oxygen species (ROS): inductions of neurite outgrowth and endothelin-2/vasoactive intestinal contractor in PC12 cells by CoCl2 are ROS dependent, but those by MnCl2 are not. Neurosci. Lett. 2007, 422:223-227.
20. Suzukawa K., Miura K., Mitsushita J., Resau J., Hirose K., Crystal R., Kamata T. Nerve growth factor-induced neuronal differentiation requires generation of Rac1-regulated reactive oxygen species. J. Biol. Chem. 2000, 275:13175-13178.
21. Saxena S., Caroni P. Mechanisms of axon degeneration: from development to disease. Prog. Neurobiol. 2007, 83:174-191.
22. Shah P., Lal N., Leung E., Traul D.E., Gonzalo-Ruiz A., Geula C. Neuronal and axonal loss are selectively linked to fibrillar amyloid-{beta} within plaques of the aged primate cerebral cortex. Am. J. Pathol. 2010, 177:325-333.
23. Salinthone S., Yadav V., Bourdette D.N., Carr D.W. Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS. Endocr. Metab. Immune Disord. Drug Targets 2008, 8:132-142.
24. Suchy J., Chan A., Shea T.B. Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance. Nutr. Res. 2009, 29:70-74.
25. Cui X., Zuo P., Zhang Q., Li X., Hu Y., Long J., Packer L., Liu J. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J. Neurosci. Res. 2006, 84:647-654.
26. Planchamp V., Bermel C., Tönges L., Ostendorf T., Kügler S., Reed J.C., Kermer P., Bähr M., Lingor P. BAG1 promotes axonal outgrowth and regeneration in vivo via Raf-1 and reduction of ROCK activity. Brain 2008, 131:2606-2619.
27. Wind S., Beuerlein K., Eucker T., Müller H., Scheurer P., Armitage M.E., Ho H., Schmidt H.H., Wingler K. Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br. J. Pharmacol. 2010, 161:885-898.
28. Petersen S.K., Moreau R.F., Smith E.J., Hagen T.M. Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. IUBMB Life 2008, 60:362-367.
29. Shay K.P., Moreau R.F., Smith E.J., Smith A.R., Hagen T.M. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim. Biophys. Acta 2009, 1790:1149-1160.
30. Moini H., Packer L., Saris N.E. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol. Appl. Pharmacol. 2002, 182:84-90.
31. Fujita H., Shiosaka M., Ogino T., Okimura Y., Utsumi T., Sato E.F., Akagi R., Inoue M., Utsumi K., Sasaki J. Alpha-lipoic acid suppresses 6-hydroxydopamine-induced ROS generation and apoptosis through the stimulation of glutathione synthesis but not by the expression of heme oxygenase-1. Brain Res. 2008, 1206:1-12.
32. Dicter N., Madar Z., Tirosh O. Alpha-lipoic acid inhibits glycogen synthesis in rat soleus muscle via its oxidative activity and the uncoupling of mitochondria. J. Nutr. 2002, 132:3001-3006.
33. D'Autréaux B., Toledano M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 2007, 8:813-824.
34. Simbula G., Columbano A., Ledda-Columbano G.M., Sanna L., Deidda M., Diana A., Pibiri M. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis 2007, 12:113-123.
35. Groeger G., Mackey A.M., Pettigrew C.A., Bhatt L., Cotter T.G. Stress-induced activation of Nox contributes to cell survival signaling via production of hydrogen peroxide. J. Neurochem. 2009, 109:1544-1554.
36. Mackey A.M., Sanvicens N., Groeger G., Doonan F., Wallace D., Cotter T.G. Redox survival signaling in retina-derived 661W cells. Cell Death Differ. 2008, 15:1291-1303.